These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

440 related items for PubMed ID: 16820607

  • 1. Impact of internal mammary artery conduit on long-term outcomes after percutaneous intervention of saphenous vein graft.
    Mehta RH, Honeycutt E, Peterson ED, Granger CB, Halabi AR, Shaw LK, Smith PK, Califf RM, Harrington RA, Sketch MH.
    Circulation; 2006 Jul 04; 114(1 Suppl):I396-401. PubMed ID: 16820607
    [Abstract] [Full Text] [Related]

  • 2. Clinical correlates of long-term mortality after percutaneous interventions of saphenous vein grafts.
    Mehta RH, Honeycutt E, Shaw LK, Glower D, Harrington RA, Sketch MH.
    Am Heart J; 2006 Oct 04; 152(4):801-6. PubMed ID: 16996861
    [Abstract] [Full Text] [Related]

  • 3. Poor long-term patient and graft survival after primary percutaneous coronary intervention for acute myocardial infarction due to saphenous vein graft occlusion.
    Brodie BR, VerSteeg DS, Brodie MM, Hansen C, Richter SJ, Stuckey TD, Gupta N, Pulsipher M, Downey W.
    Catheter Cardiovasc Interv; 2005 Aug 04; 65(4):504-9. PubMed ID: 15988742
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Long-term patency of saphenous vein and left internal mammary artery grafts after coronary artery bypass surgery: results from a Department of Veterans Affairs Cooperative Study.
    Goldman S, Zadina K, Moritz T, Ovitt T, Sethi G, Copeland JG, Thottapurathu L, Krasnicka B, Ellis N, Anderson RJ, Henderson W, VA Cooperative Study Group #207/297/364.
    J Am Coll Cardiol; 2004 Dec 07; 44(11):2149-56. PubMed ID: 15582312
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Impact of renal function on morbidity and mortality after percutaneous aortocoronary saphenous vein graft intervention.
    Gruberg L, Weissman NJ, Pichard AD, Waksman R, Kent KM, Satler LF, Suddath WO, Pinnow EE, Gevorkian N, Lindsay J.
    Am Heart J; 2003 Mar 07; 145(3):529-34. PubMed ID: 12660678
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Bypass grafts to the left anterior descending coronary artery: saphenous vein versus internal mammary artery.
    Tyras DH, Barner HB, Kaiser GC, Codd JE, Pennington DG, Willman VL.
    J Thorac Cardiovasc Surg; 1980 Sep 07; 80(3):327-33. PubMed ID: 6968006
    [Abstract] [Full Text] [Related]

  • 11. Survival benefit of exclusive use of in situ arterial conduits over combined use of arterial and vein grafts for multiple coronary artery bypass grafting.
    Nishida H, Tomizawa Y, Endo M, Kurosawa H.
    Circulation; 2005 Aug 30; 112(9 Suppl):I299-303. PubMed ID: 16159835
    [Abstract] [Full Text] [Related]

  • 12. Percutaneous coronary intervention of or through saphenous vein grafts or internal mammary arteries: the impact of stents, adjunctive pharmacology, and multicomponent distal protection.
    Morrison DA, Thai H, Goldman S, Felix E, Hernandez J.
    Catheter Cardiovasc Interv; 2006 Apr 30; 67(4):571-9. PubMed ID: 16547927
    [Abstract] [Full Text] [Related]

  • 13. Operation for two-vessel coronary artery disease: midterm results of bilateral ITA grafting versus unilateral ITA and saphenous vein grafting.
    Carrel T, Horber P, Turina MI.
    Ann Thorac Surg; 1996 Nov 30; 62(5):1289-94. PubMed ID: 8893559
    [Abstract] [Full Text] [Related]

  • 14. Long-term outcomes of the symmetry vein graft anastomosis device: a matched case-control analysis.
    Kachhy RG, Kong DF, Honeycutt E, Shaw LK, Davis RD.
    Circulation; 2006 Jul 04; 114(1 Suppl):I425-9. PubMed ID: 16820612
    [Abstract] [Full Text] [Related]

  • 15. Impact of diabetes on five-year outcomes after vein graft interventions performed prior to the drug-eluting stent era.
    Ashfaq S, Ghazzal Z, Douglas JS, Morris DC, Veledar E, Weintraub WS.
    J Invasive Cardiol; 2006 Mar 04; 18(3):100-5. PubMed ID: 16598106
    [Abstract] [Full Text] [Related]

  • 16. Outcomes of patients with acute myocardial infarction from a saphenous vein graft culprit undergoing percutaneous coronary intervention.
    Gaglia MA, Torguson R, Xue Z, Gonzalez MA, Ben-Dor I, Suddath WO, Kent KM, Satler LF, Pichard AD, Waksman R.
    Catheter Cardiovasc Interv; 2011 Jul 01; 78(1):23-9. PubMed ID: 21061247
    [Abstract] [Full Text] [Related]

  • 17. Long-term clinical outcomes of real-world experience using sirolimus-eluting stents in saphenous vein graft disease.
    Ramana RK, Ronan A, Cohoon K, Homan D, Sutherland J, Steen L, Liu J, Loeb H, Lewis BE.
    Catheter Cardiovasc Interv; 2008 Jun 01; 71(7):886-93. PubMed ID: 18412238
    [Abstract] [Full Text] [Related]

  • 18. Single versus bilateral internal thoracic artery grafts with concomitant saphenous vein grafts for multivessel coronary artery bypass grafting: effects on mortality and event-free survival.
    Stevens LM, Carrier M, Perrault LP, Hébert Y, Cartier R, Bouchard D, Fortier A, El-Hamamsy I, Pellerin M.
    J Thorac Cardiovasc Surg; 2004 May 01; 127(5):1408-15. PubMed ID: 15116000
    [Abstract] [Full Text] [Related]

  • 19. Chronic total occlusion treatment in post-CABG patients: saphenous vein graft versus native vessel recanalization-long-term follow-up in the drug-eluting stent era.
    Meliga E, García-García HM, Kukreja N, Daemen J, Tanimoto S, Ramcharitar S, van Mieghem CA, Sianos G, van der Ent M, van der Giessen WJ, de Feyter P, van Domburg R, Serruys PW.
    Catheter Cardiovasc Interv; 2007 Jul 01; 70(1):21-5. PubMed ID: 17584913
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.